OneMedNet Corporation received a letter from the staff of the Listing Qualifications department of The Nasdaq Stock Market notifying the Company that it was…
OneMedNet Corp (ONMD) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. As previously disclosed, on April 14, 2026, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it was not in compli
How this was made
The 30-second read
Why it matters
Regaining compliance eliminates a potential delisting threat, which can stabilize the share price and may attract new investors.
Market read
The news is a primary corporate disclosure with modest trading relevance; it may prompt a short‑term price uptick but lacks broader market impact.
What to watch
If the stock was already trading above $1, the compliance issue may have been priced in, limiting upside.
Background
The filing is an SEC Form 8‑K Item 8.01, reporting that OneMedNet met the Nasdaq Capital Market bid‑price rule after a grace period.
Ticker impact
OneMedNet Corp disclosed it regained Nasdaq $1.00 minimum bid price compliance on Oct 13, 2026, closing a compliance deficiency.
likely modest upside as the market prices out the compliance regain
The filing is the first public notice of compliance; no further details suggest a large catalyst, but removal of a negative risk factor typically supports the stock.
Market effects
Minimal; compliance news is company‑specific and does not affect the broader healthcare IT sector.
None; the event is confined to OneMedNet's listing status.
None
Counterpoint
Some investors may view the compliance regain as a short‑term bump and could sell into any temporary rally.
Key entities
- companyOneMedNet Corporation
US‑listed healthcare‑technology firm (ticker ONMD) that was previously out of compliance with Nasdaq's $1 bid price rule.
